BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27052378)

  • 21. The
    He Z; Xiao J; Wang J; Lu S; Zheng K; Yu M; Liu J; Wang C; Ding N; Liang M; Wu Y
    Front Immunol; 2021; 12():694573. PubMed ID: 34484191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlamydia psittaci hypothetical inclusion membrane protein CPSIT_0842 evokes a pro-inflammatory response in monocytes via TLR2/TLR4 signaling pathways.
    Xiao J; He J; He Z; Wang C; Li Y; Yan X; Chen Y; Sun Z; Liu J; Liang M; Wu Y
    Vet Microbiol; 2023 May; 280():109693. PubMed ID: 36889151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific antigens of Chlamydia pecorum and their homologues in C psittaci and C trachomatis.
    Baghian A; Kousoulas K; Truax R; Storz J
    Am J Vet Res; 1996 Dec; 57(12):1720-5. PubMed ID: 8950425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes.
    Rank RG; Batteiger BE; Soderberg LS
    Infect Immun; 1990 Aug; 58(8):2599-605. PubMed ID: 2370110
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Chen Q; Li Y; Yan X; Sun Z; Wang C; Liu S; Xiao J; Lu C; Wu Y
    Front Microbiol; 2020; 11():578009. PubMed ID: 33343522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
    McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
    Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
    Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
    J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and comparison of differentially expressed genes involved in Chlamydia psittaci persistent infection in vitro and in vivo.
    Chen Y; Wang C; Mi J; Zhou Z; Wang J; Tang M; Yu J; Liu A; Wu Y
    Vet Microbiol; 2021 Apr; 255():108960. PubMed ID: 33667981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis.
    Lu H; Xing Z; Brunham RC
    J Immunol; 2002 Dec; 169(11):6324-31. PubMed ID: 12444139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
    Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
    J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Chlamydia muridarum plasmid genes and immunogenicity of pGP3 and pGP4 in different mouse strains.
    Mosolygó T; Faludi I; Balogh EP; Szabó ÁM; Karai A; Kerekes F; Virók DP; Endrész V; Burián K
    Int J Med Microbiol; 2014 May; 304(3-4):476-83. PubMed ID: 24631212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H; Parnell M; Caldwell HD
    Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
    Murthy AK; Cong Y; Murphey C; Guentzel MN; Forsthuber TG; Zhong G; Arulanandam BP
    Infect Immun; 2006 Dec; 74(12):6722-9. PubMed ID: 17015458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant protein YbgF induces protective immunity against Rickettsia heilongjiangensis infection in C3H/HeN mice.
    Qi Y; Xiong X; Duan C; Jiao J; Gong W; Wen B
    Vaccine; 2013 Nov; 31(48):5643-50. PubMed ID: 24113261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional Analysis of 10 Selected Genes in a Model of Penicillin G Induced Persistence of Chlamydophila psittaci in HeLa Cells.
    Hu Y; Chen L; Wang C; Xie Y; Chen Z; Liu L; Su Z; Wu Y
    J Microbiol Biotechnol; 2015 Aug; 25(8):1246-56. PubMed ID: 25876597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of turkeys against Chlamydophila psittaci challenge by parenteral and mucosal inoculations and the effect of turkey interferon-gamma on genetic immunization.
    Vanrompay D; Cox E; Kaiser P; Lawson S; Van Loock M; Volckaert G; Goddeeris B
    Immunology; 2001 May; 103(1):106-12. PubMed ID: 11380698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of polyclonal and monoclonal antibodies against abortion in mice infected by Chlamydia psittaci.
    Buzoni-Gatel D; Bernard F; Andersen A; Rodolakis A
    Vaccine; 1990 Aug; 8(4):342-6. PubMed ID: 2396474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine.
    Khan SA; Polkinghorne A; Waugh C; Hanger J; Loader J; Beagley K; Timms P
    Vaccine; 2016 Feb; 34(6):775-82. PubMed ID: 26747718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.